Literature DB >> 851300

Hypocomplementemia in chronic idiopathic urticaria.

D A Mathison, C M Arroyave, K N Bhat, D S Hurewitz, D J Marnell.   

Abstract

A discrete evoking factor or presumed pathophysiologic mechanism is not recognized in the majority of patients with chronic urticaria or angioedema. Two cases are reported in which chronic urticaria was the main manifestation of an immune cutaneous vasculitis associated with hypocomplementemia attributable to classic and alternative mechanisms of complement activation. Among 72 consecutive patients evaluated for chronic urticaria, 10 additional patients with idiopathic urticaria were found to have hypocomplementemia. Of these, two had evidence of classic and alternative mechanisms of complement activation, five had evidence of only classic pathway activation, and three evidence of predominately or exclusively alternative pathway activation. Circulating immune complexes were found in the majority of patients with classic pathway activation. Hypocomplementemia may provide clues to pathophysiologic mechanisms operative in some patients with chronic urticaria.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851300     DOI: 10.7326/0003-4819-86-5-534

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

Review 1.  Urticaria and angioedema.

Authors:  B A Burrall; A C Huntley
Journal:  Clin Rev Allergy       Date:  1985-02

Review 2.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

Review 3.  Urticarial vasculitis.

Authors:  Joe Venzor; Wai L Lee; David P Huston
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

4.  The AHA syndrome: arthritis, hives and angioedema.

Authors:  D J McNeil; T D Kinsella; A M Crawford; M J Fritzler
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.